Literature DB >> 29577409

Effect of treatment of symptomatic convergence insufficiency on reading in children: a pilot study.

Mitchell Scheiman1, Christopher Chase2, Eric Borsting3, Gladys Lynn Mitchell4, Marjean T Kulp4, Susan A Cotter3.   

Abstract

BACKGROUND: To evaluate the impact of treatment of symptomatic convergence insufficiency using office-based vergence/accommodative therapy on reading skills in children.
METHODS: Children (n = 44) ages nine to 17 years with symptomatic convergence insufficiency were administered the following four reading tests: Wechsler Individual Achievement Test II; Test of Word Reading Efficiency; Test of Silent Word Reading Fluency; and the Gray Oral Reading Test, at baseline and eight weeks after completion of a 16-week program of office-based vergence/accommodative therapy. To determine whether significant change occurred with therapy, change in performance was compared to zero. Treatment response was determined using a composite score of symptoms and signs at the conclusion of treatment and at the 24-week outcome visit. Participants were classified as early responders, late responders, or non-responders based upon whether criteria for successful treatment were met at the completion of 16 weeks of treatment, at the 24-week outcome visit, or not met at either visit, respectively.
RESULTS: After treatment for convergence insufficiency, statistically significant improvements were found for reading comprehension (mean = 4.2, p = 0.009) and the reading composite score (mean = 2.4, p = 0.016) as measured by the Wechsler Individual Achievement Test at the 24-week visit. These improvements were related to the clinical treatment outcome measures (p = 0.011) with the largest improvements occurring in those who were early responders to treatment. Reading speed (words per minute) increased significantly on the Gray Oral Reading Test (p < 0.0001). No significant improvements were observed for single word reading or reading fluency as measured by the Test of Word Reading Efficiency, the Test of Silent Word Reading Fluency or the Gray Oral Reading Test.
CONCLUSION: Improvements in reading comprehension and reading composite were found after office-based vergence/accommodative therapy, with the greatest improvements in those who responded early to treatment.
© 2018 Optometry Australia.

Entities:  

Keywords:  convergence insufficiency; near point of convergence; orthoptics; reading; vision therapy

Mesh:

Year:  2018        PMID: 29577409     DOI: 10.1111/cxo.12682

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  6 in total

1.  2017 Glenn A. Fry Award Lecture: Establishing an Evidence-based Literature for Vision Therapy - A 25-year Journey.

Authors:  Mitchell M Scheiman
Journal:  Optom Vis Sci       Date:  2018-08       Impact factor: 1.973

2.  Do standard optometric measures predict binocular coordination during reading?

Authors:  Joëlle Joss; Stephanie Jainta
Journal:  J Eye Mov Res       Date:  2021-01-21       Impact factor: 0.957

Review 3.  Development of a core outcome set for evaluative research into paediatric cerebral visual impairment (CVI), in the UK and Eire.

Authors:  Anna Pease; Trudy Goodenough; Cath Borwick; Rose Watanabe; Christopher Morris; Cathy Williams
Journal:  BMJ Open       Date:  2021-09-29       Impact factor: 2.692

4.  Virtual reality-based vision therapy versus OBVAT in the treatment of convergence insufficiency, accommodative dysfunction: a pilot randomized controlled trial.

Authors:  Shijin Li; Angcang Tang; Bi Yang; Jianglan Wang; Longqian Liu
Journal:  BMC Ophthalmol       Date:  2022-04-21       Impact factor: 2.086

5.  The repeatability and reproducibility of four techniques for measuring horizontal heterophoria: Implications for clinical practice.

Authors:  Nicola S Anstice; Bianca Davidson; Bridget Field; Joyce Mathan; Andrew V Collins; Joanna M Black
Journal:  J Optom       Date:  2020-08-12

6.  Effect of Vergence/Accommodative Therapy on Reading in Children with Convergence Insufficiency: A Randomized Clinical Trial.

Authors: 
Journal:  Optom Vis Sci       Date:  2019-11       Impact factor: 1.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.